lutetium (177Lu) chloride

Lutetium-177Lu chloride is a therapeutic radioisotope solution, specifically the no-carrier-added (n.c.a.) form of the Lutetium-177 isotope. Developed by Chengdu New Radiomedicine Technology for the Chinese market, it serves as a precursor or raw material for the synthesis of radiopharmaceuticals used in targeted radionuclide therapy (TRT) and radioligand therapy (RLT). Lutetium-177 is a beta-emitting isotope with a half-life of approximately 6.7 days, which allows for the delivery of ionizing radiation to specific tumor cells when conjugated to targeting molecules like peptides or antibodies. The n.c.a. form is preferred for its high specific activity, which is crucial for labeling ligands with high affinity and low receptor density.

Brand names

Lutetium (177Lu) chloride Billev

Other names

lutetium-177Lu chloridelutetium177Lu chloridelutetium 177Lu chlorideLutetium-177 Chloride Solution n.c.a.Lutetium177 Chloride Solution n.c.a.Lutetium 177 Chloride Solution n.c.a.177Lu Chloride SolutionLutetium-177 chlorideLutetium177 chlorideLutetium 177 chloride